• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

CTI files for initial public offering

Article

PET developer CTI may soon go public. The privately held firm based in Knoxville, TN, has filed with the Securities and Exchange Commission to issue an IPO. The company hopes to raise about $230 million, according to Wall Street Research Net. The lead

PET developer CTI may soon go public. The privately held firm based in Knoxville, TN, has filed with the Securities and Exchange Commission to issue an IPO. The company hopes to raise about $230 million, according to Wall Street Research Net. The lead underwriter will be CS First Boston. CTI had annual revenues of $188.9 million and net income of $6.4 million in fiscal 2001, which ended Sept. 30. The company employs 620 full- and part-time staff, according to WSRN.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.